MILFORD, Mass., Dec. 17, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra Ph.D., Waters President and Chief Executive Officer, will participate in a fireside chat at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13th, 2025 at 2:15 PM Pacific Time (5:15 PM Eastern Time). A live webcast of the event will be available on the 'Events & Presentations' section of Waters Investor Relations website at https://ir.waters.com. A replay of the webcast will be available ...

MILFORD, Mass., Nov. 20, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra Ph.D., Waters President and Chief Executive Officer, will participate in a fireside chat at the 7th Annual Evercore HealthCONx Conference on Wednesday, December 4th, 2024 at 10:00AM Eastern Time.A live webcast of the event will be available on the 'Events & Presentations' section of Waters Investor Relations website at https://ir.waters.com. A replay of the webcast will be available for 90 days.About Waters ...

News summary: Newly built 45,000 sq ft facility houses engineering and skilled manufacturing employees at Longbridge Business Park, a specialized hub for science and technology. Waters triples manufacturing footprint while increasing precision machining and metrology capacity to support future growth. New facility was constructed to BREEAM Very Good standard and achieved the highest Energy Performance Certificate rating. LONGBRIDGE, England, Nov. 13, 2024 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announ ...

News Summary: waters_connect™ Data Intelligence software provides laboratories with comprehensive business intelligence on their chromatographic data throughout the product development lifecycle, enabling real-time audit readiness and query response, while reducing time spent on audit preparation. Cloud-based software proactively provides visibility into risks that could trigger adverse regulatory findings, delivering seamless remote data access, comprehensive analytics, historical trends, scalability, and ...

Waters Corporation (WAT) has reported third-quarter 2024 non-GAAP earnings of $2.93 per share, beating the Zacks Consensus Estimate by 9.33%. The company had registered earnings of $2.84 in the year-ago quarter, decreasing 3.2% on a year-over-year basis.Net sales of $740.3 million topped the Zacks Consensus Estimate of $711.7 million. The figure increased 4% on a reported and a constant-currency basis from the year-ago quarter’s readings.Waters saw a strong third quarter, with sales exceeding the high end o ...

Waters (WAT) came out with quarterly earnings of $2.93 per share, beating the Zacks Consensus Estimate of $2.68 per share. This compares to earnings of $2.84 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 9.33%. A quarter ago, it was expected that this maker of products used in drug discovery and development would post earnings of $2.55 per share when it actually produced earnings of $2.63, delivering a surprise of 3.14%.Over ...

Highlights Sales of $740 million exceeded guidance, grew 4% as reported and 4% in constant currency Instruments returned to growth; recurring revenue grew high single-digits in constant currency All reported regions returned to growth in the quarter; sales grew across all end markets, led by Pharma & Industrial GAAP EPS of $2.71 and non-GAAP EPS of $2.93 significantly exceeded guidance, led by strong operational performance and better-than-expected market conditions Raised full-year sales and EPS guidance, ...

The Barnacle is a quantitative analyst and has been in and out of the investing business since 2003. He is a former member of Marketocracy's M100 Club. He has a degree in mathematics and believes that mathematics is the root of all success. If the numbers tell one to do something, then do it. When one reads his posts, one will realize that. Consequently, he does not put much stock in sell-side analysis, since most of it is pretty bad. he will share posts about value stocks that still have growth potential. ...

The market expects Waters (WAT) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended September 2024. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on November 1, 2024, might help the stock move higher if these key numbers are be ...

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Waters (WAT) , which belongs to the Zacks Medical - Instruments industry, could be a great candidate to consider.This maker of products used in drug discovery and development has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. The average surprise for the last two quarters was 4.19%.For the most re ...